These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 28446567)
1. Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Sa Q; Ochiai E; Tiwari A; Mullins J; Shastri N; Mercier C; Cesbron-Delauw MF; Suzuki Y J Immunol; 2017 Jun; 198(11):4425-4434. PubMed ID: 28446567 [No Abstract] [Full Text] [Related]
2. Strain- and Dose-Dependent Reduction of Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841 [No Abstract] [Full Text] [Related]
3. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979 [TBL] [Abstract][Full Text] [Related]
4. Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii. Schaeffer M; Han SJ; Chtanova T; van Dooren GG; Herzmark P; Chen Y; Roysam B; Striepen B; Robey EA J Immunol; 2009 May; 182(10):6379-93. PubMed ID: 19414791 [TBL] [Abstract][Full Text] [Related]
5. Importance of CD8(+)Vbeta8(+) T cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice. Wang X; Claflin J; Kang H; Suzuki Y J Interferon Cytokine Res; 2005 Jun; 25(6):338-44. PubMed ID: 15957957 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice. Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929 [TBL] [Abstract][Full Text] [Related]
7. Rhoptry and Dense Granule Secreted Effectors Regulate CD8 Rommereim LM; Fox BA; Butler KL; Cantillana V; Taylor GA; Bzik DJ Front Immunol; 2019; 10():2104. PubMed ID: 31555296 [No Abstract] [Full Text] [Related]
9. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis. Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873 [TBL] [Abstract][Full Text] [Related]
10. A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention. Suzuki Y Parasitol Int; 2021 Apr; 81():102259. PubMed ID: 33271362 [TBL] [Abstract][Full Text] [Related]
11. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. Kwok LY; Lütjen S; Soltek S; Soldati D; Busch D; Deckert M; Schlüter D J Immunol; 2003 Feb; 170(4):1949-57. PubMed ID: 12574363 [TBL] [Abstract][Full Text] [Related]
12. Dense granule protein 3 of Mani R; Abdelaziz MH; Ochiai E; Sa Q; Fox BA; Bzik DJ; Suzuki Y Front Immunol; 2023; 14():1272221. PubMed ID: 37868957 [No Abstract] [Full Text] [Related]
13. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
14. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. Khan IA; Kasper LH J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333 [TBL] [Abstract][Full Text] [Related]